Clinical Trial Update: Efficacy and Safety In Poorly Controlled Type 2 Diabetics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing efficacy and safety in poorly controlled Type 2 diabetes patients has been completed. The study was sponsored by GlaxoSmithKlin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED